Zai Lab (ZLAB) EBIT (2020 - 2026)
Zai Lab's (ZLAB) quarterly EBIT came in at -$69.4 million in Q1 2026, down 23.22% year-on-year from -$90.4 million in Q1 2025, and little changed quarter-over-quarter from -$69.4 million in Q4 2025.
Zai Lab (ZLAB) EBIT (2020 - 2026) Analysis & Trends
Zai Lab has disclosed EBIT across 7 years of filings, most recently posting -$69.4 million for Q1 2026.
- EBIT for Q1 2026 came in at -$69.4 million, down 23.22% year-over-year; the trailing twelve-month figure through Mar 2026 was -$242.5 million (up 9.55% YoY), and the FY2025 annual result was -$229.4 million, up 18.67% from the prior year.
- EBIT came in at -$69.4 million for Q1 2026 at Zai Lab, roughly flat from -$69.4 million in the prior quarter.
- In the past five years, EBIT ranged from a high of -$48.8 million in Q3 2025 to a low of -$128.6 million in Q3 2022.
- The 5-year median for EBIT is -$70.3 million (2024), against an average of -$79.5 million.
- Peak annual rise in EBIT reached 64.88% in 2022, while the deepest fall reached 54.54% in 2022.
- Zai Lab's EBIT stood at -$97.3 million in 2022, then slipped by 27.43% to -$124.0 million in 2023, then surged by 45.24% to -$67.9 million in 2024, then retreated by 2.23% to -$69.4 million in 2025, then climbed by 0.03% to -$69.4 million in 2026.
- The last three EBIT figures came in at -$69.4 million (Q1 2026), -$69.4 million (Q4 2025), and -$48.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | -69.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.39 Mn |
| Dec 31, 2025 | -69.41 Mn |
| Sep 30, 2025 | -48.82 Mn |
| Jun 30, 2025 | -54.90 Mn |
| Mar 31, 2025 | -56.31 Mn |
| Dec 31, 2024 | -67.89 Mn |
| Sep 30, 2024 | -67.85 Mn |
| Jun 30, 2024 | -76.06 Mn |
| Mar 31, 2024 | -70.31 Mn |
| Dec 31, 2023 | -123.98 Mn |
| Sep 30, 2023 | -83.57 Mn |
| Jun 30, 2023 | -89.50 Mn |
| Mar 31, 2023 | -69.52 Mn |
| Dec 31, 2022 | -97.29 Mn |
| Sep 30, 2022 | -128.58 Mn |
| Jun 30, 2022 | -98.72 Mn |
| Mar 31, 2022 | -79.76 Mn |
| Dec 31, 2021 | -219.20 Mn |
| Sep 30, 2021 | -83.21 Mn |
| Jun 30, 2021 | -170.57 Mn |